ECOR Earnings Date: Nov 4, 2026 (Estimated) — electroCore, Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is ECOR's next earnings date?
electroCore, Inc. (ECOR) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.27 on revenue of $10.9M.
How did ECOR do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), electroCore, Inc. posted EPS of -$0.33 versus the -$0.42 estimate, a beat of 19.5%. Revenue was $9.4M against a $9.5M estimate. The stock's 1-day post-earnings move was +20.7%.
How much does ECOR stock move after earnings?
ECOR beat EPS estimates in 4 of its last 7 reported quarters. Over the last 8 reports the stock moved an average of 18.0% (up or down) in the day after earnings.
About electroCore, Inc.
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.42 | -0.33 | +19.51% | $9.4M | ✅ Beat | +20.75% | +48.36% | +37.46% |
| 2026-05-06 | Q1 2026 | -0.61 | -0.59 | +3.28% | $9.6M | ✅ Beat | -5.86% | -5.11% | +30.93% |
| 2026-03-26 | FY 2025 | -1.40 | 0.09 | +106.29% | $55.9M | ✅ Beat | -10.01% | -1.35% | -7.70% |
| 2026-03-19 | Q4 2025 | -0.37 | -0.34 | +8.11% | $9.2M | ✅ Beat | -4.65% | -8.16% | -3.74% |
| 2025-11-05 | Q3 2025 | -0.38 | -0.40 | -5.26% | $8.7M | ❌ Miss | +23.21% | +27.85% | +1.69% |
| 2025-08-06 | Q2 2025 | -0.32 | -0.44 | -37.50% | $7.4M | ❌ Miss | -29.15% | -25.83% | -29.44% |
| 2025-05-07 | Q1 2025 | — | -0.47 | — | $6.7M | — | -23.79% | -32.38% | -15.86% |
| 2025-03-12 | Q4 2024 | -0.34 | -0.40 | -17.65% | $7.0M | ❌ Miss | -26.54% | -38.38% | -57.54% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q3 FY25 · $8.3M total
| Segment | Share | Revenue | YoY | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 99.2% | $8.2M | +35.5% | $5.0M | $5.7M | $6.1M | $12.3M |
| Other Countries | 0.6% | $48K | +220.0% | $45K | $22K | $15K | $59K |
| JAPAN | 0.2% | $17K | +6.3% | $19K | $15K | $16K | $30K |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.